Acquisition of Anacor Pharmaceuticals Inc (NASDAQ:ANAC) Under Investigation for Investors

San Diego, CA -- (SBWIRE) -- 05/23/2016 -- The acquisition of biopharmaceutical company Anacor Pharmaceuticals Inc by Pfizer Inc is under investigation over potential wrongdoing. The investigation was announced for investors, who currently hold shares of Anacor Pharmaceuticals Inc (NASDAQ:ANAC), concerning whether the takeover of Palo Alto, CA based Anacor Pharmaceuticals Inc. by Pfizer Inc for $99.25 per share is unfair.